Diabetes Business Overview
Dedicated to Delivering the Best
Our insulin pumps and continuous glucose monitoring devices meet both paediatric needs and adult requirements. We design our products so that both children and adults living with insulin-dependent diabetes can enjoy life the way they want to.
Effectively controlling glucose levels (or gaining improved glycaemic control) can help patients with diabetes to reduce the long term health risks associated with diabetes and to improve their quality of life.
Insulin Pump Technology
An insulin pump delivers precise doses of insulin, continuously allowing the user to program a pattern of insulin delivery tailored to their needs. Insulin is delivered to the body through a tiny tube called a cannula, and an infusion set that is below the skin and replaced every three days. The pump can be discreetly clipped to a belt, slipped into a pocket, or worn under clothing. Insulin pump technology can provide the user with better blood glucose control than multiple daily injections*. The MiniMed® Paradigm® Veo™ is the world’s first and only insulin pump and continuous glucose monitoring system that includes an automatic Low Glucose Suspend feature. This feature allows the Paradigm Veo insulin pump to automatically suspend insulin infusion when a patient’s glucose levels fall below their pre-determined threshold. The Low Glucose Suspend feature requires the use of continuous glucose monitoring. The Low Glucose Suspend feature:
- Automatically halts insulin infusion when glucose levels reach a pre-determined threshold and the user is unresponsive to alarms.
- Provides increased protection against severe low blood glucose - even when patients are asleep.
- Is a safety feature which could benefit children, teens and adults.
The MiniMed® Paradigm® Veo™ insulin pump resumes insulin delivery after a two-hour suspension, without user intervention.
Continuous Glucose Monitoring
A continuous glucose monitoring system consists of a tiny sensor which is inserted under the skin to continuously measure glucose levels in the body and a monitor to record and display the glucose measurements every 5 minutes. The continuous glucose monitoring system can also warn of increasing or decreasing glucose levels and can be downloaded for a complete and accurate picture of glucose patterns over time.
Web and PC-based Software Solutions
Our software tools integrate insulin pump, continuous glucose monitoring and BG metre data. The broad sets of data are transformed into meaningful information that support healthcare providers in optimising the pump technology and easy to use reports that can help people with diabetes better manage their condition. The advanced internet-enabled functionality allows for the synchronisation of data available to patients and providers and offers the possibility to monitor patients' data remotely.
Consumables
These include infusion sets and insulin reservoirs used in conjunction with insulin pumps. Medtronic infusion sets reflect more than 20 years of customer feedback - which is why they are so easy to use, convenient and comfortable to wear. Each infusion set model was designed with specific users in mind to best match individual body types and lifestyles.
Accessories
Our wide range of accessories enhances the design and handling of the pump, from novelty and replaceable “SKINS” (pump covers) to cases, clips and carriers. There are accessories to suit the tastes of both adults and children.
Real Progress Toward an Artificial Pancreas
In 1983 Medtronic Diabetes pioneered continuous insulin delivery. Our first insulin pump was introduced in an undertaking to find a "better way" for people with type 1 diabetes to receive insulin.
Since then our business has maintained its reputation for excellence in insulin pump technology and continuous glucose monitoring through innovation and continual demonstration of efficacy and safety through clinical evidence.
For nearly 30 years we have been steadfastly and steadily working towards achieving a dream: an artificial pancreas for diabetes. We are dedicated to that goal.
Reference
- * Doyle EA. Weinzimer, Steffen AT, Ahern JAH, Vincent M, Tamborlane WV. A randomized prospective trial comparing the efficacy of insulin pump therapy with multiple daily injections using insulin glargine. Diabetes Care. 2004; 27(7): 1554-1558
- Print Page
- E-mail Page
- A
- A
- A Text Size
Additional information
Camp Oki
The Medtronic Foundation is pleased to support Camp Oki, a summer camp for children with congenital heart disease. With staff support from the Hospital for Sick Children's Cardiac Program, the camp operates a free one-week program in Muskoka for children with pacemakers and defibrillators.